Insilixa

Developer of point-of-care diagnostics system based on semiconductor-based CMOS biochip technology

placeSunnyvale, California, United States calendar_todayFounded 2012 groups40 employees language insilixa.com

Registered entities

Innovation

9 patent families (6 granted) — focus: Chemistry & metallurgy, Physics & computing, Electricity & electronics, Operations & transport; filing pace steady. Cited 2,811 times.

YearFilings
20162
20174
20182
20194
20203
20212
20223
20232
20241
20254
20263

Investor mix

4 investors on record; lead investors include PointGuard Ventures, Morningside.

Investor typeCountShare
Venture capital250%
Other / undisclosed250%
Coming soon